With a generic cliff approaching, the 505(b)(2) development process can make changes to reference products for greater profit potential and lower risk. Camargo Pharmaceutical Services offers a clear process to identify products that have documented market differentiation:
- Selection criteria
- Identify, assess and rank unmet needs
- Defend the value and maximize investment
- Narrow to one candidate
- The 505(b)(2) development plan
- Product case history’s
For differentiated product benefits, embark on a 505(b)(2) with Camargo.
See us at the AAPS 2012 Annual Meeting, booth #4800.